Recent Finacing
Recent Raise
Paradigm Diagnostics develops PCDx, a clinical NGS and proteomic tumor test analyzing DNA, RNA and protein at >5,000x coverage to report therapeutic associations and return results in 3–5 days.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Paradigm Diagnostics.
